Further studies revealed that FEZF1-AS1 could simultaneously recruit EZH2 and LSD1 promoter regions to P57, and inhibit their transcription, thus promoting the occurrence and development of LAD [46]. The gene discussed is FEZF1; the disease is leukocyte adhesion deficiency.